CHIR-98014

2595-5
EUR 414

CHIR 99021

1677-100 Ask for price

CHIR 99021

1677-25
EUR 892

CHIR 99021

1677-5
EUR 311

CHIR-090

B1852-25
EUR 675

CHIR-090

B1852-5
EUR 207

CHIR-124

E1KS2683 2mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 325

CHIR-124

A8394-25 25 mg
EUR 340
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-5 5 mg
EUR 151
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-5.1 10 mM (in 1mL DMSO)
EUR 160
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-50 50 mg
EUR 537
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014

A8395-10 10 mg
EUR 212
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-25 25 mg
EUR 374
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-5 5 mg
EUR 148
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-5.1 10 mM (in 1mL DMSO)
EUR 197
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-50 50 mg
EUR 595
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-090

A3307-10 10 mg
EUR 382
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-200 200 mg
EUR 2716
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-5 5 mg
EUR 254
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-5.1 10 mM (in 1mL DMSO)
EUR 253
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-50 50 mg
EUR 1225
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-98014

HY-13076 50mg
EUR 753

CHIR-124

HY-13263 50mg
EUR 670

CHIR-090

HY-15460 50mg
EUR 1359

CHIR-99021

HY-10182 10mg
EUR 173

Ezsolution? CHIR-98014

2639-1
EUR 153

CHIR 99021 trihydrochloride

B1199-25
EUR 865

CHIR 99021 trihydrochloride

B1199-5
EUR 294

CHIR 99021 trihydrochloride

B5779-10 10 mg
EUR 224

CHIR 99021 trihydrochloride

B5779-25 25 mg
EUR 441

CHIR 99021 trihydrochloride

B5779-5 5 mg
EUR 145

CHIR-99021 (CT99021)

E1KS1263 2mg
EUR 325

RAF265 (CHIR-265)

E1KS2161 10mg
EUR 1504

CHIR-99021 (CT99021)

A3011-10 10 mg
EUR 171
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-100 100 mg
EUR 693
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-25 25 mg
EUR 293
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-5 5 mg
EUR 131
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-5.1 10 mM (in 1mL DMSO)
EUR 166
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-S Evaluation Sample
EUR 81
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (monohydrochloride)

HY-10182A 50mg
EUR 725

CHIR-99021 (trihydrochloride)

HY-10182B 50mg
EUR 725

CHIR-99021 (CT99021) HCl

A8396-10 10 mg
EUR 171
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-100 100 mg
EUR 693
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-25 25 mg
EUR 293
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-5 5 mg
EUR 131
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-S Evaluation Sample
EUR 81
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 98014, GSK-3 Inhibitor

BC214-005 5 mg
EUR 313

CHIR 98014, GSK-3 Inhibitor

BC214-010 10 mg
EUR 381

CHIR 98014, GSK-3 Inhibitor

BC214-050 50 mg
EUR 874

Dovitinib (TKI-258, CHIR-258)

A2168-25 25 mg
EUR 224
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1].

Dovitinib (TKI-258, CHIR-258)

A2168-5 5 mg
EUR 108
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1].

CHIR 99021, GSK-3 Inhibitor , HCl

BC213-005 5 mg
EUR 286

CHIR 99021, GSK-3 Inhibitor , HCl

BC213-025 25 mg
EUR 847

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-002 2 mg
EUR 178

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-005 5 mg
EUR 265

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-010 10 mg
EUR 315

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-025 25 mg
EUR 394

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-100 100 mg
EUR 887